The Immunity and Pathogens Division is positioned to address the growing complexity of global health challenges, especially at the intersection between pandemics, climate change, and the emergence of new infectious diseases. It offers a holistic approach to understanding and facing threats to public health caused by microscopic pathogens. The Immunity and Pathogens Division is situated within the complex interaction between pathogens, human beings and the environment.
This division is dedicated to revealing the molecular mechanisms related to emerging viral illnesses and neglected diseases, which lack measures for treatment and prevention and have an especially strong impact on more socioeconomically vulnerable populations.
This group studies diseases caused by microorganisms which are highly prevalent in tropical countries and affect a large portion of the global population that lives in socially and economically vulnerable conditions
Expanding the understanding of diseases, identifying molecular targets for personalized therapies, and translating discoveries into health benefits
Implementing methods for scientific results on the cutting-edge of knowledge, playing a vital role in developing and new experimental approaches and putting them into action
Acting as a catalyst and carrying out complex tasks, transforming scientific knowledge into technologies for Brazilian healthcare
Enables radical innovation in pharmaceuticals in Brazil through the sustainable use of biodiversity in connection with cutting-edge science and high technology